145 related articles for article (PubMed ID: 8359651)
1. Flow cytometry and Zollinger-Ellison syndrome: relationship to clinical course.
Metz DC; Kuchnio M; Fraker DL; Venzon DJ; Jaffe G; Jensen RT; Stetler-Stevenson M
Gastroenterology; 1993 Sep; 105(3):799-813. PubMed ID: 8359651
[TBL] [Abstract][Full Text] [Related]
2. The gastrinoma/Zollinger-Ellison syndrome: statistical evaluation of a Japanese series of 359 cases.
Soga J; Yakuwa Y
J Hepatobiliary Pancreat Surg; 1998; 5(1):77-85. PubMed ID: 9683758
[TBL] [Abstract][Full Text] [Related]
3. Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment.
Cadiot G; Lehy T; Ruszniewski P; Bonfils S; Mignon M
Dig Dis Sci; 1993 Jul; 38(7):1307-17. PubMed ID: 8100759
[TBL] [Abstract][Full Text] [Related]
4. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma.
Fraker DL; Norton JA; Alexander HR; Venzon DJ; Jensen RT
Ann Surg; 1994 Sep; 220(3):320-8; discussion 328-30. PubMed ID: 7916560
[TBL] [Abstract][Full Text] [Related]
5. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT
Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671
[TBL] [Abstract][Full Text] [Related]
6. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy in pancreatic neuroendocrine tumors.
Alanen KA; Joensuu H; Klemi PJ; Marin S; Alavaikko M; Nevalainen TJ
Am J Clin Pathol; 1990 Jun; 93(6):784-8. PubMed ID: 2346135
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
[TBL] [Abstract][Full Text] [Related]
9. [Are there differences between sporadic and MEN-1 associated gastrinomas?].
Layer P
Z Gastroenterol; 1991 Jun; 29(6):313-4. PubMed ID: 1681627
[No Abstract] [Full Text] [Related]
10. [Surgical therapy of gastrinoma with associated Zollinger-Ellison syndrome].
Schröder W; Hölscher AH; Beckurts KT; Schusdziarra V; Höfler H; Siewert JR
Z Gastroenterol; 1996 Aug; 34(8):465-72. PubMed ID: 8967120
[TBL] [Abstract][Full Text] [Related]
11. Nuclear DNA analysis of insulinomas and gastrinomas.
Stipa F; Arganini M; Bibbo M; Straus F; Dytch H; Wied G; Horvath K; Kaplan EL
Surgery; 1987 Dec; 102(6):988-98. PubMed ID: 2825371
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine neoplasm, type 1. Gastrinomas, pancreatic neoplasms, microcarcinoids, the Zollinger-Ellison syndrome, lymph nodes, and hepatic metastases.
Shepherd JJ; Challis DR; Davies PF; McArdle JP; Teh BT; Wilkinson S
Arch Surg; 1993 Oct; 128(10):1133-42. PubMed ID: 8105768
[TBL] [Abstract][Full Text] [Related]
13. The place for curative surgical procedures in the treatment of sporadic and familial Zollinger-Ellison syndrome.
Delcore R; Friesen SR
Curr Opin Gen Surg; 1994; ():69-76. PubMed ID: 7584013
[TBL] [Abstract][Full Text] [Related]
14. Gastrin-producing ovarian mucinous cystadenomas: a cause of the Zollinger-Ellison syndrome.
Primrose JN; Maloney M; Wells M; Bulgim O; Johnston D
Surgery; 1988 Nov; 104(5):830-3. PubMed ID: 3187898
[TBL] [Abstract][Full Text] [Related]
15. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.
Pipeleers-Marichal M; Somers G; Willems G; Foulis A; Imrie C; Bishop AE; Polak JM; Häcki WH; Stamm B; Heitz PU
N Engl J Med; 1990 Mar; 322(11):723-7. PubMed ID: 1968616
[TBL] [Abstract][Full Text] [Related]
16. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT
Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of the need for long-term antisecretory therapy in patients with Zollinger-Ellison syndrome following successful curative gastrinoma resection.
Metz DC; Benya RV; Fishbeyn VA; Pisegna JR; Orbuch M; Strader DB; Norton JA; Jensen RT
Aliment Pharmacol Ther; 1993 Jun; 7(3):247-57. PubMed ID: 8364130
[TBL] [Abstract][Full Text] [Related]
18. Zollinger-Ellison syndrome. Recent advances in the management of the gastrinoma.
Vinayek R; Frucht H; Chiang HC; Maton PN; Gardner JD; Jensen RT
Gastroenterol Clin North Am; 1990 Mar; 19(1):197-217. PubMed ID: 2184129
[TBL] [Abstract][Full Text] [Related]
19. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form.
Gibril F; Venzon DJ; Ojeaburu JV; Bashir S; Jensen RT
J Clin Endocrinol Metab; 2001 Nov; 86(11):5282-93. PubMed ID: 11701693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
